Antibiotic prescription for HIV-positive patients in primary health care in Mozambique: A cross-sectional study.
HIV
antibiotics
drug interactions
drug resistance
prescription
primary health care
Journal
Southern African journal of infectious diseases
ISSN: 2313-1810
Titre abrégé: S Afr J Infect Dis
Pays: South Africa
ID NLM: 101646666
Informations de publication
Date de publication:
2022
2022
Historique:
received:
20
09
2021
accepted:
24
11
2021
entrez:
14
3
2022
pubmed:
15
3
2022
medline:
15
3
2022
Statut:
epublish
Résumé
Antibiotic overuse is a major public health challenge worldwide and it can result in the emergence and spread of drug resistance. In Mozambique, there are limited data related to primary care physicians' antibiotic prescription patterns. The aim of this study was to assess the antibiotic prescription patterns for HIV- positive patients in primary health care. A prospective cross-sectional quantitative study was conducted in eight primary health care units in Southern Mozambique. The study was based on recording outpatient prescriptions using a structured questionnaire. Three hundred and sixty-nine prescriptions and clinical records of HIV-positive patients from 31 prescribers were assessed. A total of eight general practitioners, 13 medical technicians and 10 nurses participated. Antibiotics were used in 65.9% of prescriptions, with an average of 0.9 antibiotics per prescription. Of a total of 334 prescribed antibiotics, 69.8% were for the treatment of infections and 30.2% for prophylaxis. Penicillin (29.2%), sulphonamides (19.7%), and quinolones (16.3%) were the most prescribed classes of antibiotics for treatment. For prophylaxis, only sulphonamides (93.1%) and macrolides (6.9%) were prescribed. The diagnosis was the only variable that had a significant association with antibiotic prescription ( The prescription of antibiotics was high and influenced by patient clinical conditions. Antibiotics were prescribed either for treatment or prophylaxis of infections, mostly to treat respiratory tract infections. Prescribers should be encouraged to adopt a rational use of antibiotics to reduce unnecessary prescriptions.
Sections du résumé
Background
UNASSIGNED
Antibiotic overuse is a major public health challenge worldwide and it can result in the emergence and spread of drug resistance. In Mozambique, there are limited data related to primary care physicians' antibiotic prescription patterns. The aim of this study was to assess the antibiotic prescription patterns for HIV- positive patients in primary health care.
Methods
UNASSIGNED
A prospective cross-sectional quantitative study was conducted in eight primary health care units in Southern Mozambique. The study was based on recording outpatient prescriptions using a structured questionnaire. Three hundred and sixty-nine prescriptions and clinical records of HIV-positive patients from 31 prescribers were assessed. A total of eight general practitioners, 13 medical technicians and 10 nurses participated.
Results
UNASSIGNED
Antibiotics were used in 65.9% of prescriptions, with an average of 0.9 antibiotics per prescription. Of a total of 334 prescribed antibiotics, 69.8% were for the treatment of infections and 30.2% for prophylaxis. Penicillin (29.2%), sulphonamides (19.7%), and quinolones (16.3%) were the most prescribed classes of antibiotics for treatment. For prophylaxis, only sulphonamides (93.1%) and macrolides (6.9%) were prescribed. The diagnosis was the only variable that had a significant association with antibiotic prescription (
Conclusion
UNASSIGNED
The prescription of antibiotics was high and influenced by patient clinical conditions. Antibiotics were prescribed either for treatment or prophylaxis of infections, mostly to treat respiratory tract infections. Prescribers should be encouraged to adopt a rational use of antibiotics to reduce unnecessary prescriptions.
Identifiants
pubmed: 35284563
doi: 10.4102/sajid.v37i1.340
pii: SAJID-37-340
pmc: PMC8905412
doi:
Types de publication
Journal Article
Langues
eng
Pagination
340Informations de copyright
© 2022. The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.
Références
Curr Infect Dis Rep. 2001 Jun;3(3):224-232
pubmed: 11384552
Cad Saude Publica. 2008 Aug;24(8):1791-800
pubmed: 18709220
Curr Opin Microbiol. 1999 Oct;2(5):494-8
pubmed: 10508727
HIV Med. 2020 Jan;21(1):53-63
pubmed: 31532898
Am J Trop Med Hyg. 2010 Jul;83(1):152-7
pubmed: 20595494
Int J Antimicrob Agents. 1999 Jan;11(1):23-30
pubmed: 10075274
Antimicrob Agents Chemother. 2009 Jun;53(6):2450-4
pubmed: 19332670
J Bras Pneumol. 2008 Oct;34(10):822-8
pubmed: 19009216
Cad Saude Publica. 2007 Jan;23(1):95-104
pubmed: 17187108
Scand J Prim Health Care. 2009;27(4):208-15
pubmed: 19929185
Br J Clin Pharmacol. 2015 Feb;79(2):182-94
pubmed: 24730660
BMJ. 2003 Jan 18;326(7381):138
pubmed: 12531847
PLoS One. 2011;6(6):e19717
pubmed: 21695194
BMJ Open. 2019 Nov 25;9(11):e029260
pubmed: 31772084
J Antimicrob Chemother. 2015 Dec;70(12):3317-22
pubmed: 26286575
Biochemistry. 2014 Mar 18;53(10):1565-74
pubmed: 24576155
Expert Opin Investig Drugs. 2003 Jul;12(7):1165-77
pubmed: 12831351
Proc Am Thorac Soc. 2011 Jun;8(3):294-300
pubmed: 21653531
Cien Saude Colet. 2008 Apr;13 Suppl:689-96
pubmed: 21936173
J Am Acad Nurse Pract. 2005 Oct;17(10):416-24
pubmed: 16181264
Lancet Infect Dis. 2007 Oct;7(10):686-93
pubmed: 17897611
MMWR Recomm Rep. 2009 Sep 4;58(RR-11):1-166
pubmed: 19730409
AIDS. 2002 Jan 4;16(1):75-83
pubmed: 11741165
S Afr Med J. 2018 Mar 28;108(4):304-310
pubmed: 29629681
Int J Tuberc Lung Dis. 2001 Oct;5(10):894-902
pubmed: 11605881
BMC Res Notes. 2014 Feb 25;7:110
pubmed: 24568650
Pediatr Infect Dis J. 2000 Sep;19(9):938-43
pubmed: 11001130
Trop Med Int Health. 2013 Apr;18(4):485-94
pubmed: 23294446
Pan Afr Med J. 2012;12:103
pubmed: 23133703
Ann Intern Med. 2001 Mar 20;134(6):490-4
pubmed: 11255526
Prev Med. 2002 Mar;34(3):346-52
pubmed: 11902851